Genomic mutation testing is critical to therapeutic selection and management of patients with colorectal cancer. In a new multicenter study, researchers compared a new cartridge-based laboratory testing device called the Idylla automated system (Biocartis) to current standard-of-care testing methods.
from News Medical Medical Research News Feed https://ift.tt/2NvuSYv
0 Comments